These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 16785607)

  • 1. Fibroblast growth factor-2 and epidermal growth factor modulate prolactin responses to TRH and dopamine in primary cultures.
    Spuch C; Diz-Chaves Y; Pérez-Tilve D; Mallo F
    Endocrine; 2006 Apr; 29(2):317-24. PubMed ID: 16785607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute effect of basic fibroblast growth factor on secretion of prolactin as assessed by the reverse hemolytic plaque assay.
    Larson GH; Koos RD; Sortino MA; Wise PM
    Endocrinology; 1990 Feb; 126(2):927-32. PubMed ID: 2105207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of specific protein kinase C isozymes in mediating epidermal growth factor, thyrotropin-releasing hormone, and phorbol ester regulation of the rat prolactin promoter in GH4/GH4C1 pituitary cells.
    Pickett CA; Manning N; Akita Y; Gutierrez-Hartmann A
    Mol Endocrinol; 2002 Dec; 16(12):2840-52. PubMed ID: 12456804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential involvement of protein kinase C in basal versus acetylcholine-regulated prolactin secretion in rat anterior pituitary cells during aging.
    Pu HF; Liu TC
    J Cell Biochem; 2002; 86(2):268-76. PubMed ID: 12111996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor and thyrotropin-releasing hormone act similarly on a clonal pituitary cell strain. Modulation of hormone production and inhbition of cell proliferation.
    Schonbrunn A; Krasnoff M; Westendorf JM; Tashjian AH
    J Cell Biol; 1980 Jun; 85(3):786-97. PubMed ID: 6771298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolactin regulation by heparin-binding growth factors expressed in mouse pituitary cell lines.
    Hnasko R; Ben-Jonathan N
    Endocrine; 2003; 20(1-2):35-44. PubMed ID: 12668866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropeptide Y suppresses prolactin secretion from rat anterior pituitary cells: evidence for interactions with dopamine through inhibitory coupling to calcium entry.
    Wang J; Ciofi P; Crowley WR
    Endocrinology; 1996 Feb; 137(2):587-94. PubMed ID: 8593806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of guanine nucleotide-binding proteins, Gi alpha 3 and Gs alpha, in dopamine and thyrotropin-releasing hormone signal transduction: evidence for competition and commonality.
    Kineman RD; Gettys TW; Frawley LS
    J Endocrinol; 1996 Mar; 148(3):447-55. PubMed ID: 8778223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of prolactin-releasing response to salsolinol (SAL) and thyrotropin-releasing hormone (TRH) in ruminants.
    Hashizume T; Onodera Y; Shida R; Isobe E; Suzuki S; Sawai K; Kasuya E; Nagy GM
    Domest Anim Endocrinol; 2009 Feb; 36(2):99-104. PubMed ID: 19070987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolactin-releasing Peptide (PrRP) increases prolactin responses to TRH in vitro and in vivo.
    Spuch C; Diz-Chaves Y; Pérez-Tilve D; Alvarez-Crespo M; Mallo F
    Endocrine; 2007 Apr; 31(2):119-24. PubMed ID: 17873321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism(s) by which the transient removal of dopamine regulation potentiates the prolactin-releasing action of thyrotropin-releasing hormone.
    Martinez de la Escalera G; Weiner RI
    Neuroendocrinology; 1988 Mar; 47(3):186-93. PubMed ID: 3129665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of age and long term ovariectomy on prolactin secretion, as assessed by the reverse hemolytic plaque assay.
    Sortino MA; Wise PM
    Endocrinology; 1989 Jan; 124(1):90-6. PubMed ID: 2491812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catecholamines and pituitary function. III. Restoration of the prolactin response to thyrotropin-releasing hormone by low-dose dopamine infusion in women with pathological hyperprolactinemia.
    Nicoletti I; Filipponi P; Fedeli L; Sfrappini M; Gregorini G; Ambrosi F; Santeusanio F
    Horm Res; 1984; 20(3):202-12. PubMed ID: 6436160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyrotropin-releasing hormone and epidermal growth factor stimulate prolactin synthesis by a pathway(s) that differs from that used by phorbol esters: dissociation of actions by calcium dependency and additivity.
    Ramsdell JS; Tashjian AH
    Endocrinology; 1985 Nov; 117(5):2050-60. PubMed ID: 3930223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin increases prolactin and modifies the effects of fgf-2 upon prolactin accumulation in pituitary primary cultures.
    Spuch C; Diz-Chaves Y; Pérez-Tilve D; Mallo F
    Endocrine; 2004 Jul; 24(2):131-6. PubMed ID: 15347838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of dopamine on thyrotropin-releasing hormone-induced prolactin secretion in vitro.
    Fagin KD; Neill JD
    Endocrinology; 1981 Dec; 109(6):1835-40. PubMed ID: 6796383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dihydropyridine-sensitive calcium channel activity related to prolactin, growth hormone, and luteinizing hormone release from anterior pituitary cells in culture: interactions with somatostatin, dopamine, and estrogens.
    Drouva SV; Rerat E; Bihoreau C; Laplante E; Rasolonjanahary R; Clauser H; Kordon C
    Endocrinology; 1988 Dec; 123(6):2762-73. PubMed ID: 2461851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Semicircadian rhythm of dopamine release in the mediobasal hypothalamus in awake rats during pseudopregnancy: evidence that a thyrotropin-releasing hormone analogue stimulates dopamine release and thereby inhibits prolactin secretion.
    Timmerman W; Poelman RT; Westerink BH; Schuiling GA
    Neuroendocrinology; 1995 Nov; 62(5):434-43. PubMed ID: 8559275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient removal of dopamine potentiates the stimulation of prolactin release by TRH but not VIP: stimulation via Ca2+/protein kinase C pathway.
    Martínez de la Escalera G; Guthrie J; Weiner RI
    Neuroendocrinology; 1988 Jan; 47(1):38-45. PubMed ID: 3124014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between salsolinol (SAL) and thyrotropin-releasing hormone (TRH) or dopamine (DA) on the secretion of prolactin in ruminants.
    Hashizume T; Shida R; Suzuki S; Kasuya E; Kuwayama H; Suzuki H; Oláh M; Nagy GM
    Domest Anim Endocrinol; 2008 Apr; 34(3):327-32. PubMed ID: 17976947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.